Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Some children may develop hair loss after having COVID-19.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Lower LDL-c levels predict higher COVID-19 mortality.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and lesions.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.